MCID: RBS001
MIFTS: 51

Rabies malady

Rare diseases, Infectious diseases, Neuronal diseases categories

Aliases & Classifications for Rabies

About this section
Sources:
10Disease Ontology, 45NIH Rare Diseases, 47Novoseek, 12DISEASES, 51Orphanet, 35MedlinePlus, 2CDC, 65UMLS, 36MeSH, 29ICD9CM, 59SNOMED-CT, 42NCIt, 28ICD10 via Orphanet, 37MESH via Orphanet, 66UMLS via Orphanet, 27ICD10
See all sources

Aliases & Descriptions for Rabies:

Name: Rabies 10 45 47 12 51 35 2 65 36
 
Lyssa 10 45


Classifications:



Characteristics (Orphanet epidemiological data):

51
rabies:
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe); Age of onset: All ages; Age of death: any age


External Ids:

Disease Ontology10 DOID:11260
ICD9CM29 071
MeSH36 D011818
NCIt42 C28182
Orphanet51 770
ICD10 via Orphanet28 A82.0, A82.1, A82.9
MESH via Orphanet37 D011818
UMLS via Orphanet66 C0034494
ICD1027 A82, A82.9

Summaries for Rabies

About this section
MedlinePlus:35 Rabies is a deadly animal disease caused by a virus. it can happen in wild animals, including raccoons, skunks, bats and foxes, or in dogs, cats or farm animals. people get it from the bite of an infected animal. in people, symptoms of rabies include fever, headache and fatigue, then confusion, hallucinations and paralysis. once the symptoms begin, the disease is usually fatal. a series of shots can prevent rabies in people exposed to the virus. you need to get them right away. if an animal bites you, wash the wound well; then get medical care. to help prevent rabies vaccinate your pet. rabies vaccines are available for dogs, cats and farm animals don't let pets roam don't approach stray animals. animals with rabies might be aggressive and vicious, or tired and weak centers for disease control and prevention

MalaCards based summary: Rabies, also known as lyssa, is related to erythema multiforme and acquired immunodeficiency syndrome, and has symptoms including hallucinations, vocal cord paresis and diarrhea. An important gene associated with Rabies is PML (Promyelocytic Leukemia), and among its related pathways are Peginterferon alpha-2a/Peginterferon alpha-2b Pathway (Hepatocyte), Pharmacodynamics and Interferon Pathway. Affiliated tissues include brain or, brain and spinal cord, and related mouse phenotypes are tumorigenesis and cellular.

Disease Ontology:10 A viral infectious disease that results in inflammation located in brain or located in spinal cord, has material basis in rabies virus, which is transmitted by bite of an infected animal, or transmitted by contact of mucous membranes with saliva of an infected animal. the infection has symptom fever, has symptom headache, has symptom prickling or itching sensation at the site of bite, has symptom anxiety, has symptom confusion, has symptom agitation, has symptom delirium, has symptom difficulty swallowing, has symptom hydrophobia, and has symptom paralysis.

CDC:2 Rabies is a preventable viral disease of mammals most often transmitted through the bite of a rabid animal. The vast majority of rabies cases reported to the Centers for Disease Control and Prevention (CDC) each year occur in wild animals like raccoons, skunks, bats, and foxes.

Wikipedia:68 Rabies is a viral disease that causes acute inflammation of the brain in humans and other warm-blooded... more...

Related Diseases for Rabies

About this section

Diseases related to Rabies via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 125)
idRelated DiseaseScoreTop Affiliating Genes
1erythema multiforme30.1ALB, CXCL10, TLR3
2acquired immunodeficiency syndrome29.6CCL5, CXCL10, MX1
3viral infectious disease10.7
4encephalitis10.6
5neuronitis10.5
6viral encephalitis10.4
7trichohepatoenteric syndrome 210.4
8japanese encephalitis10.3
9ethmoid sinus adenocarcinoma10.3ALB, PML
10neurilemmoma of the fifth cranial nerve10.3ALB, PML
11vaccinia10.2
12tetanus10.2
13rubella10.2CCL5, NCAM1
14adult xanthogranuloma10.2ALB, STAT1
15testicular cancer10.2CD40LG, PML
16leukemia, acute promyelocytic, somatic10.2NCAM1, PML, STAT1
17yellow fever10.2ALB, NGFR
18theileriasis10.2CD40LG, NCAM1
19parasitic protozoa infectious disease10.2CD40LG, NCAM1
20mandibular cancer10.1ALB, CD40LG
21pulmonary hemosiderosis10.1CD40LG, STAT1
22cycloplegia10.1CD40LG, PML
23fowler's syndrome10.1ALB, CD40LG
24typhoid fever10.1ALB, CD40LG
25vascular skin disease10.1ALB, CD40LG
26ampulla of vater small cell carcinoma10.1CD40LG, NCAM1
27disease of mental health10.1ALB, CD40LG
28keratoderma hereditarium mutilans with ichthyosis10.1CD40LG, IGHM
29central nervous system chondroma10.1ALB, CD40LG
30malaria10.1
31muscle disorders10.1
32myelitis10.1
33rhinotracheitis10.1
34st. louis encephalitis10.1
35muscle tissue disease10.1
36myopathy10.1
37poliomyelitis10.1
38purpura10.1
39stomatitis10.1
40transverse myelitis10.1
41stork bite10.1PML, STAT1
42selective igm deficiency disease10.1CD40LG, IGHM
43cerebellar vermis medulloblastoma10.1CD40LG, NCAM1, PML
44hypersensitivity reaction type iv disease10.1ALB, CD40LG
45wrinkles10.1CD40LG, IGHM
46lemierre's syndrome10.1ALB, CD40LG, PML
47cauda equina syndrome10.1CD40LG, STAT1, STAT2
48cervicomedullary junction neoplasm10.1CCL5, CD40LG
49breast intracanalicular fibroadenoma10.0CD40LG, MX1
50primary systemic mycosis10.0ALB, CD40LG, PML

Graphical network of the top 20 diseases related to Rabies:



Diseases related to rabies

Symptoms for Rabies

About this section

Symptoms:

 51 10 (show all 29)
  • pharyngitis
  • hypersialorrhea
  • nausea/vomiting/regurgitation/merycism/hyperemesis
  • acute diarrhea
  • larynx/laryngeal palsy
  • facial pain/cephalalgia/migraine
  • paresthesia/dysesthesia/hypoesthesia/anesthesia/numbness
  • insomnia
  • hyperactivity/attention deficit
  • psychic/behavioural troubles
  • delirium/hallucination
  • anorexia
  • humour troubles/anxiety/depression/apathy/euphoria/irritability
  • fever/chilling
  • motor deficit/trouble
  • acute palsy
  • collapse/sudden death/cardiac arrest/cardiorespiratory arrest
  • seizures/epilepsy/absences/spasms/status epilepticus
  • obnubilation/coma/lethargia/desorientation
  • fever
  • headache
  • prickling or itching sensation at the site of bite
  • anxiety
  • confusion
  • agitation
  • delirium
  • difficulty swallowing
  • hydrophobia
  • paralysis

HPO human phenotypes related to Rabies:

(show all 16)
id Description Frequency HPO Source Accession
1 hallucinations hallmark (90%) HP:0000738
2 vocal cord paresis hallmark (90%) HP:0001604
3 diarrhea hallmark (90%) HP:0002014
4 nausea and vomiting hallmark (90%) HP:0002017
5 anorexia hallmark (90%) HP:0002039
6 migraine hallmark (90%) HP:0002076
7 paresthesia hallmark (90%) HP:0003401
8 excessive salivation hallmark (90%) HP:0003781
9 abnormality of temperature regulation hallmark (90%) HP:0004370
10 attention deficit hyperactivity disorder hallmark (90%) HP:0007018
11 recurrent pharyngitis hallmark (90%) HP:0100776
12 insomnia hallmark (90%) HP:0100785
13 cerebral palsy typical (50%) HP:0100021
14 seizures occasional (7.5%) HP:0001250
15 sudden cardiac death occasional (7.5%) HP:0001645
16 reduced consciousness/confusion occasional (7.5%) HP:0004372

Drugs & Therapeutics for Rabies

About this section

Drugs for Rabies (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
ProguanilapprovedPhase 436500-92-54923, 6178111
Synonyms:
(1E)-1-[amino-(4-chloroanilino)methylidene]-2-propan-2-ylguanidine
(hydrochloride)
1-(P-Chlorophenyl)-5-isopropylbiguanide
1-(p-Chlorophenyl)-5-isopropylbiguanide
1-Isopropyl-5-(4-chlorophenyl)biguanide
4-12-00-01198 (Beilstein Handbook Reference)
46920-30-3
500-92-5
637-32-1
637-32-1 (HYDROCHLORIDE)
AB00053776
AC1O1QGA
BIDD:GT0576
BPBio1_001207
BRD-K28183345-003-05-6
BRN 2811599
BSPBio_001097
BSPBio_003417
Bigumal
C11H16ClN5
CAS-637-32-1
CHEBI:8455
CHEMBL1377
CID6178111
Chlorguanid
Chlorguanide
Chloriguane
Chloroguanide
DB01131
Diguanyl (hydrochloride)
DivK1c_006763
Drinupal (hydrochloride)
EINECS 207-915-6
KBio1_001707
KBio2_002068
KBio2_004636
KBio2_007204
 
KBio3_002637
KBioGR_001204
KBioSS_002068
LS-43869
M-4888 (hydrochloride)
N-(4-Chlorophenyl)-N'-(1-methylethyl)imidodicarbonimidic diamide
N-(4-Chlorophenyl)-N'-(isopropyl)-imidodicarbonimidic diamide
N-(4-Chlorophenyl)-n'-(isopropyl)-imidodicarbonimidic diamide
N-(4-chlorophenyl)-N'-(propan-2-yl)imidodicarbonimidic diamide
N1-p-Chlorophenyl-N5-isopropylbiguanide
NCGC00016528-01
NCGC00016528-02
NCGC00016528-03
NSC12977
Paludrin
Paludrine (hydrochloride)
Palusil (hydrochloride)
Prestwick0_000999
Prestwick1_000999
Prestwick2_000999
Prestwick3_000999
Proguanil [INN:BAN]
Proguanile
Proguanile [DCIT]
Proguanilum
Proguanilum [INN-Latin]
RP-3359
SN-12837 (hydrochloride)
SPBio_001029
SPBio_002988
SpecPlus_000667
Spectrum2_001135
Spectrum3_001659
Spectrum4_000622
Spectrum5_001384
Spectrum_001588
Tirian (hydrochloride)
UNII-S61K3P7B2V
proguanil
2
chloroquineapprovedPhase 413754-05-72719
Synonyms:
( -)-Chloroquine
(+)-Chloroquine
(-)-Chloroquine
(R)-(-)-Chloroquine
3377 RP opalate
3545-67-3
50-63-5
54-05-7
56598-66-4
58175-86-3
58175-87-4
7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline
7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline
AB00053436
AC1L1EB8
AC1Q2ZA7
AC1Q2ZA8
Amokin
Aralen
Aralen HCl
Arechin
Arechine
Arequin
Arolen
Arthrochin
Artrichin
Avlochlor
Avloclor
BPBio1_000655
BRD-A91699651-065-01-1
BRN 0482809
BSPBio_000595
BSPBio_002001
Bemaco
Bemaphate
Bemasulph
Benaquin
Bipiquin
C07625
C18H26ClN3
CCRIS 3439
CHEBI:3638
CHEMBL76
CID2719
CQ
CU-01000012392-2
Capquin
Chemochin
Chingamin
Chloraquine
Chlorochin
Chlorochine
Chlorochinum
Chloroin
Chloroquin
Chloroquina
Chloroquine
Chloroquine (USP/INN)
Chloroquine (VAN)
Chloroquine Bis-Phosphoric Acid
Chloroquine Phosphate
Chloroquine [USAN:INN:BAN]
Chloroquine phosphate
Chloroquinium
Chloroquinum
Chloroquinum [INN-Latin]
Chlorquin
Cidanchin
Clorochina
Clorochina [DCIT]
Cloroquina
Cloroquina [INN-Spanish]
Cocartrit
D02366
DB00608
Dawaquin
Delagil
Dichinalex
DivK1c_000404
EINECS 200-191-2
Elestol
Gontochin
Gontochin phosphate
HMS2090O03
HSDB 3029
Heliopar
Hydroxychloroquine Sulfate
IDI1_000404
Imagon
Ipsen 225
 
Iroquine
KBio1_000404
KBio2_000592
KBio2_003160
KBio2_005728
KBio3_001221
KBioGR_000778
KBioSS_000592
Khingamin
Klorokin
LS-141726
Lapaquin
Lopac0_000296
Malaquin
Malaquin (*Diphosphate*)
Malaren
Malarex
Mesylith
Miniquine
MolMap_000009
MolPort-001-783-623
N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine
N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine
N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine
NCGC00015256-04
NCGC00162120-01
NCI60_000894
NINDS_000404
NSC 187208
NSC14050
NSC187208
Neochin
Nivachine
Nivaquine
Nivaquine B
Nivaquine b
Pfizerquine
Plaquenil
Prestwick0_000548
Prestwick1_000548
Prestwick2_000548
Prestwick3_000548
Quinachlor
Quinagamin
Quinagamine
Quinercyl
Quingamine
Quinilon
Quinoscan
RP 3377
RP-3377
Resochen
Resochin
Resoquina
Resoquine
Reumachlor
Reumaquin
Rivoquine
Ro 01-6014/N2
Ronaquine
Roquine
SMP2_000034
SN 6718
SN-7618
SPBio_000174
SPBio_002516
ST 21
ST 21 (pharmaceutical)
Sanoquin
Silbesan
Siragan
Solprina
Sopaquin
Spectrum2_000127
Spectrum3_000341
Spectrum4_000279
Spectrum5_000707
Spectrum_000132
Tanakan
Tanakene
Tresochin
Trochin
UNII-886U3H6UFF
W 7618
WIN 244
WLN: T66 BNJ EMY1&3N2&2 IG
chloroquine
nchembio.215-comp4
nchembio.368-comp8
nchembio.87-comp17
{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine
3
Doxycyclineapproved, investigationalPhase 4204564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
4
AtovaquoneapprovedPhase 43195233-18-474989
Synonyms:
2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(trans-4-(P-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione
2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione
3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
566C
566C80
566C80 hydroxynaphthoquinone
566C80, hydroxynaphthoquinone
94015-53-9
95233-18-4
AB00513855
AC-15237
AC1L2MZG
AC1Q6E9K
AR-1H7607
ATO & IL-12
ATOVAQUONE
Acuvel
Atavaquone
Atovaquone
Atovaquone & Interleukin 12
Atovaquone (USP/INN)
Atovaquone [USAN:BAN:INN]
BIDD:GT0849
BPBio1_000603
BSPBio_000547
BSPBio_002681
BW 556C-80
BW 566C
BW 566C-80
BW 566C80
BW-A 566C
Bio-0115
C06835
C22H19ClO3
CAS-95233-18-4
CHEBI:478315
CHEBI:575568
CHEMBL1450
CID74989
CRL-8131 & Atovaquone
Compound 566
D00236
D053626
 
DB01117
DRG-0084
DivK1c_006782
FT-0081084
Glaxo Wellcome brand of atovaquone
GlaxoSmithKline brand of atovaquone
HMS1569L09
HMS1922F19
HMS2089M14
HMS2093C10
HSDB 7083
I06-0872
KBio1_001726
KBio2_002223
KBio2_004791
KBio2_007359
KBio3_001901
KBioGR_001594
KBioSS_002223
LS-178256
MLS002153863
Malarone Pediatric
Mepron
Mepron (TN)
Mepron (antipneumocystic)
MolPort-003-666-542
MolPort-003-844-665
MolPort-006-666-289
NCGC00016961-01
NCGC00016961-02
NCGC00095113-01
NCGC00095113-02
Prestwick0_000534
Prestwick1_000534
Prestwick2_000534
Prestwick3_000534
SMR001233220
SPBio_001849
SPBio_002468
SPECTRUM1504210
STK636160
SpecPlus_000686
Spectrum2_001665
Spectrum3_000991
Spectrum4_001117
Spectrum5_001382
Spectrum_001743
Wellvone
atovaquone GlaxoSmithKline brand
hydroxynaphthoquinone 566C80
hydroxynaphthoquinone, 566C80
pron
5Atovaquone, proguanil drug combinationPhase 422
6AnthelminticsPhase 4363
7Chloroquine diphosphatePhase 413750-63-5
8
LactitolPhase 3313585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
9
Miconazoleapproved, investigationalPhase 2291222916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
Desenex
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Makesense
Micantin (nitrate)
Micatin
 
Miconasil Nitrate
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Oravig
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
Rash Relief Antifungal
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
10
ZidovudineapprovedPhase 248930516-87-135370
Synonyms:
-Azido-3&prime
-deoxythymidine
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine
3&prime
3' Azido 2',3' Dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-Dideoxythymidine
3'-Azido-3'-deoxythymidine
3'-Azido-3'-deoxythymidine & Concanavalin A
3'-Azido-3'-deoxythymidine & Erythropoietin
3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19
3'-Azido-3'-deoxythymidine & Interleukin-1
3'-Azido-3'-deoxythymidine & Interleukin-2
3'-Azido-3'-deoxythymidine & Interleukin-6
3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6
3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon
3'-Azido-3'-deoxythymidine & Sho-Saiko-To
3'-Azido-3'-deoxythymidine (AIDS)
3'-Azido-3'deoxythymidine & Interferon .alpha.
3'-Azidothymidine
3'-Deoxy-3'-azidothymidine
3'-azido-3'-deoxythymidine, AZT
3-Azido-3-deoxythymidine
30516-87-1
399024-19-2
A2169_SIGMA
AC1L1TKL
AC1Q2OEK
AZT
AZT & CD4(178)-PE 40
AZT & Colony-stimulating factor 2
AZT & Concanavalin A (ConA)
AZT & EPO
AZT & GM-CSF
AZT & HPA
AZT & IFN.alpha.
AZT & IL-1
AZT & IL-2
AZT & IL-6
AZT & Interferon-.alpha.-2
AZT & Li & EPO
AZT & Li & GM-CSF
AZT & Li & IL-1
AZT & Li & IL-6
AZT & Lymphoblastoid Interferon
AZT & NP (from PHCA or HSA)
AZT & PM-19
AZT & SST
AZT & rIFN.alpha.2
AZT & rsCD4 & rIFN.alpha.A
AZT & rsT4
AZT & sCD4
AZT & srCD4
AZT (Antiviral)
AZT Antiviral
AZT TRANSPLACENTAL CARCINOGENESIS STUDY
AZT+PRO 140
AZT, Antiviral
Antiviral AZT
Apo-Zidovudine
Azidothymidine
Aztec
BB_NC-1012
BPBio1_000403
BRD-K72903603-001-04-6
BSPBio_000365
BSPBio_003153
BW A509U
BW-A 509U
BW-A-509U
BW-A509U
BWA 509U
BWA-509U
BWA509U
C07210
CCRIS 105
CHEBI:10110
CHEBI:127307
CHEMBL129
CID35370
CPD000058351
 
Compound S
Cpd S
D00413
D015215
DB00495
DRG-0004
DS-4152 & AZT
DivK1c_000524
HMS1921J20
HMS2090G11
HMS2092D06
HMS501K06
HSDB 6515
IDI1_000524
Interferon AD + 3'-azido-3'-deoxythymidine
Intron A & AZT
K7 [P Ti2 W10 O40]
KBio1_000524
KBio2_001828
KBio2_004396
KBio2_006964
KBio3_002653
KBioGR_000703
KBioSS_001828
LS-1159
Liposomal AZT-SN-1
Liposomal AZT-SN-3
MLS000028548
MLS001055351
MLS001076358
MLS002153202
MLS002222249
Met-SDF-1.beta. & AZT
Met-SDF-1.beta. & Zidovudine
MolPort-002-507-286
NCGC00023945-03
NCGC00023945-04
NCGC00023945-05
NCGC00023945-08
NCGC00178237-01
NCGC00178237-02
NINDS_000524
NSC 602670
Novo-Azt
PC-SOD+AZT
Prestwick3_000333
Propolis+AZT
Racemic Liposomal AZT
Retrovir
Retrovir (TN)
Retrovir(TM)
SAM002548971
SMR000058351
SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SPBio_000834
SPECTRUM1502109
STK801891
Spectrum2_000927
Spectrum3_001507
Spectrum4_000332
Spectrum5_001101
Spectrum_001348
UNII-4B9XT59T7S
ZDV
ZIDOVUDINE [AZT]
ZINC03779042
ZVD
Zidovudin
Zidovudina
Zidovudina [Spanish]
Zidovudine
Zidovudine (JAN/USP/INN)
Zidovudine EP III
Zidovudine [USAN:INN:BAN:JAN]
Zidovudine+PRO 140
Zidovudinum
Zidovudinum [Latin]
antiviral
azidodeoxythymidine
rIFN-beta seron & AZT
racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
zidovudin
zidovudine
11
Aluminum hydroxideapprovedPhase 2, Phase 1169
Synonyms:
Al(OH)3
Aluminiumhydroxid
 
Aluminum Hydroxide
Aluminum hydroxide
Dermadrox
12
Lamivudineapproved, investigationalPhase 2575134678-17-460825
Synonyms:
(+/-) (Cis)-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(+/-)-3TC
(+/-)-BCH-189
(+/-)-SddC
(-)-(2'R,5'S)-1-[2'-Hydroxymethyl-5'-(1,3-oxathiolanyl)]cytosine
(-)-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
(-)-1-[(2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-2'-Deoxy-3'-thiacytidine
(-)-BCH 189
(-)-BCH-189
(-)-SddC
(-)-beta-L-2',3'-Dideoxy-3'-thiacytidine
(-)NGPB-21
(2R,cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
.beta.-L-(-)-2',3'-dideoxy-3'-thiacytidine & Sho-Saiko-To
134678-17-4
2',3' Dideoxy 3' thiacytidine
2',3'-Dideoxy-3'-thiacytidine
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (+/-) (Cis)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Galanthus Nivalis Agglutinin (GNA)
2(1H)-Pyrimidinone, 4-amino-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl], (-)(2R,5S) & Hippeastrum hybrid agglutinin( HHA)
3'-Thia-2',3'-dideoxycytidine
3-TC
3TC
3TC & GNA
3TC & SST
3TC (AIDS INITIATIVE) (AIDS INITIATIVE)
3TC and NV-01
3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine
4-Amino-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
480434-79-5
AC-1416
AC1L1TZZ
AC1Q6C34
BCH 189
BCH-189
BCH-790
BCH189
BIDD:GT0033
Bio-0652
C07065
C8H11N3O3S
CCRIS 9274
CHEBI:133986
CHEMBL141
CID60825
CPD000466319
D00353
D019259
DB00709
 
DRG-0126
DTHC
Epivir
Epivir (TN)
Epivir HBV
Epivir(TM)
Epivir-HBV
Epzicom
FT-0082667
GG-714
GR 109714 X
GR 109714X
GR-109714X
GR109714X
HHA & 3TC
HHA & Lamivudine
HMS2051D21
HSDB 7155
Hepitec
Heptivir
Heptodin
Heptovir
L0217
LMV
LS-2107
Lamivir
Lamivudin
Lamivudina
Lamivudine
Lamivudine & GNA
Lamivudine (JAN/USP/INN)
Lamivudine [USAN:BAN:INN]
Lamivudine [USAN:INN:BAN]
Lamivudine [Usan:Ban:Inn]
Lamivudine, (2S-cis)-Isomer
Lamivudinum
MLS000759424
MLS001424097
MolPort-002-507-347
NCGC00159341-03
NCGC00159341-04
NSC620753
S1706_Selleck
SAM001246582
SAM002589994
SMR000466319
STK801940
UNII-2T8Q726O95
ZINC00012346
Zeffix
Zefix
beta-L-2',3'-Dideoxy-3'-thiacytidine
beta-L-3'-Thia-2',3'-dideoxycytidine
lamivudine
13
Efavirenzapproved, investigationalPhase 2390154598-52-464139
Synonyms:
(-)-6-CHLORO-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
(-)-Efavirenz
(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
(S)-6-chloro-4-Cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[D][1,3]oxazin-2-one
154598-52-4
1ikv
1ikw
2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)- (9
6-chloro-4-(2-Cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[D][1,3]oxazin-2-one
6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
AC-19049
AC1L20IX
BIDD:GT0383
C08088
C14H9ClF3NO2
CHEBI:119486
CHEMBL223228
CID64139
CPD000466351
D00896
DB00625
DB07709
DMP 266
DMP-266
EFV
 
EFZ
Efavirenz
Efavirenz (JAN/INN)
Efavirenzum
Eravirenz
HMS2051J08
HMS2090N16
HSDB 7163
L 743726
L-741211
L-743,726
L-743725
L-743726
LS-173464
MLS000759465
MLS001424087
Met-SDF-1.beta. & Efavirenz
Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
MolPort-003-983-924
NSC742403
SAM001246667
SBB066062
SMR000466351
Stocrin
Strocin (TM)
Sustiva
Sustiva (TM)
Sustiva (TN)
UNII-JE6H2O27P8
ZINC02020233
efavirenz
efavirenz, (S)-isomer
zoxazin-2-one
Éfavirenz
14
Abacavirapproved, investigationalPhase 2200136470-78-565140, 441300, 441300, 65140
Synonyms:
(+/-)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
(+/-)-Abacavir
(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
136470-78-5
1592U89
168146-84-7
ABC
AC1L9AXG
Abacavir
Abacavir (INN)
Abacavir Sulfate
Abacavir [INN]
Bio-0001
C07624
 
CHEBI:421707
CHEMBL1380
CID441300
D07057
DB01048
Epzicom
NCGC00164560-01
NCGC00164560-02
NSC742406
Trizivir
ZINC02015928
Ziagen
Ziagen (TM)(*Succinate salt*)
[(1S,4R)-4-[2-amino-6-(cyclopropylamino)purin-9-yl]cyclopent-2-en-1-yl]methanol
abacavir
{(1S-cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-2-en-1-yl}methanol
15Lamivudine, zidovudine drug combinationPhase 2110
16CyclosporinsPhase 2849
17
QS 21Phase 238141256-04-4
Synonyms:
 
Stimulon
18
Vitamin Aapproved, nutraceuticalPhase 138611103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2e,4e,6e,8e)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Chocola a
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A palmitate
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin a
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
19KrestinPhase 1184
20MF59 oil emulsionPhase 192
21Retinol palmitatePhase 1386
22retinolNutraceuticalPhase 1386
23
Stavudineapproved, investigational1713056-17-518283
Synonyms:
1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine
1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione
1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione
1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2
132425-31-1
2',3' Didehydro 3' deoxythymidine
2',3'-Anhydrothymidine
2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (DDI)
2',3'-Didehydro-2',3'-dideoxythmidine
2',3'-Didehydro-3'-deoxythimidine
2',3'-Didehydro-3'-deoxythymidine
3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor
3'-Deoxy-2',3'-didehydrothymidine
3'-Deoxy-2'-thymidinene
3056-17-5
AC-5263
AC1L2BQ9
AC1Q6BSH
BB_NC-1008
BIDD:GT0082
BMY 27857
BMY-27857
BMY27857
BRN 0618327
Bristol-Myers Brand of Stavudine
Bristol-Myers Squibb Brand of Stavudine
C07312
CHEBI:207119
CHEMBL991
CID18283
CPD000058350
CPD000673569
D 1413
D 4T
D 4T (nucleoside)
D00445
D018119
D1413_SIGMA
D3580
D4T & GM-CSF
D4TMBY-27857-3
DB00649
Dideoxydidehydrothymidine
EU-0100336
Estavudina
Estavudina [INN-Spanish]
FT-0082665
 
HMS2051O20
HSDB 7338
LS-1160
Lopac0_000336
MLS000028546
MLS000759504
MLS001055348
MLS001077292
MolPort-002-507-283
NCGC00023212-03
NCGC00023212-04
NCGC00023212-05
NCGC00023212-07
NCGC00023212-08
NCGC00023212-09
NCGC00023212-10
NSC 163661
NSC163661
SAM001246729
SAM002589948
SMR000058350
SMR000673569
STK801888
STV
Sanilvudine
Sanilvudine (JAN)
Stavudin
Stavudine
Stavudine (USAN/INN)
Stavudine [USAN:BAN:INN]
Stavudine [USAN:INN:BAN]
Stavudine [Usan:Ban:Inn]
Stavudine, Monosodium Salt
Stavudinum
Stavudinum [INN-Latin]
Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)- (7CI,8CI)
UNII-BO9LE4QFZF
ZINC00137884
Zent
Zerit
Zerit (TN)
Zerit Xr
Zerit(TM)
Zerut XR
d4T
ddeThd
ddeTyd
sanilvudine
stavudine
24
Lopinavirapproved338192725-17-092727
Synonyms:
(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)
192725-17-0
1mui
2o4s
2q5k
2rkf
2rkg
A 157378
A 157378.0
A-157378-0
A-157378.0
AB1
ABT 157378
ABT 378
ABT-378
ABT-378, LOPINAVIR
AC1L3OPJ
AIDS032937
Aluviran
C12871
C37H48N4O5
 
CHEBI:40456
CHEMBL729
CID92727
D01425
DB01601
Kaletra
Koletra
LPV
LS-173766
Lopinavir
Lopinavir (JAN/USAN/INN)
Lopinavir [USAN:INN:BAN]
MolPort-003-848-410
N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE
NCGC00164576-01
NCGC00164576-02
RS-346
S1380_Selleck
SID124893167
SID144205757
SID50111692
UNII-2494G1JF75
a-157378-0
a-157378.0
25
Ritonavirapproved, investigational833155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir

Interventional clinical trials:

(show top 50)    (show all 87)
idNameStatusNCT IDPhase
1Rabies Immune Plasma Booster StudyCompletedNCT01063140Phase 4
2The Protection Effect of Speeda® Rabies Vaccine for Human UseCompletedNCT01827917Phase 4
3Immunogenicity and Safety of Verorab™ in Indian PopulationCompletedNCT00260351Phase 4
4Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure SchedulesCompletedNCT01365494Phase 4
5The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human UseCompletedNCT01821911Phase 4
6Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIGRecruitingNCT01137045Phase 4
7Diagnostic Immunization With Rabies Vaccine in Patients With PIDRecruitingNCT02490956Phase 4
8Immunogenicity of Rabies Vaccine for Pre ExposureActive, not recruitingNCT02374814Phase 4
9Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster DoseEnrolling by invitationNCT01173302Phase 4
10Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis.Not yet recruitingNCT02564471Phase 4
11Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies VaccineCompletedNCT01339312Phase 3
12Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of AgeCompletedNCT02177032Phase 3
13Early Rabies Vaccine Immunization in Primary School ChildrenCompletedNCT01107275Phase 3
14Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult SubjectsCompletedNCT01662440Phase 3
15Safety and Immunogenicity of Freeze-dried Rabies Vaccine(MRC-5 Cell) in Chinese HumansCompletedNCT02288286Phase 3
16A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese SubjectsCompletedNCT02491541Phase 3
17A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3
18Purified Rabies Vaccine for Human Use (Chick-embryo Cell)CompletedNCT00345319Phase 3
19Safety and Immunogenicity (Non-inferiority) of a Purified Chick Embryo Cell Vaccine Vaccine Administered in Two Different Schedules (Conventional Versus Abbreviated Schedule)CompletedNCT00825305Phase 3
20A Randomized, Open-label Study Comparing Two Different Rabies Vaccine Schedules in Chinese Children and Older AdultsCompletedNCT01680016Phase 3
21Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and ChildrenCompletedNCT01148459Phase 3
22Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in AfricaCompletedNCT00866619Phase 3
23Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis RegimenRecruitingNCT01622062Phase 3
24Simplifying the Rabies Pre-exposure VaccinationActive, not recruitingNCT01388985Phase 3
25A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.Active, not recruitingNCT02545517Phase 3
26Phase II/III Study of the Safety and Effectiveness of HRIG With Co-administration of Active Rabies Vaccine in Healthy SubjectsActive, not recruitingNCT02040090Phase 2, Phase 3
27An Extended Follow up of a RTS,S/AS01E Malaria Vaccine TrialActive, not recruitingNCT00872963Phase 2, Phase 3
28Single Center, Open Label, Follow up Study in Subjects Who Previously Received Rabies Vaccine as Simulated Post-Exposure RegimenTerminatedNCT01067079Phase 3
29Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure RegimenCompletedNCT01877395Phase 2
30Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis RegimenCompletedNCT01930357Phase 2
31Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure UseCompletedNCT01784874Phase 2
32Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy AdultsCompletedNCT01228383Phase 2
33Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in ToddlersCompletedNCT00694460Phase 2
34Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy AdultsCompletedNCT00948272Phase 2
35Rabies Immunization Concomitant With JEV in ChildrenCompletedNCT00703521Phase 2
36A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult SubjectsCompletedNCT00656097Phase 2
37Randomized Phase II Trial on Safety and Neutralizing Activity of CL184 and Rabies Vaccine Versus Human Rabies Immune Globulin (HRIG) and Rabies Vaccine in Children and AdolescentsCompletedNCT00708084Phase 2
38Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects.CompletedNCT02559921Phase 2
39Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in MaliCompletedNCT00460525Phase 2
40Increasing HAART-Induced Immune Restoration With CyclosporineCompletedNCT00031070Phase 2
41Efficacy of Malaria Vaccines in Kenyan AdultsCompletedNCT01666925Phase 2
42Efficacy of Candidate Malaria Vaccines in Senegalese AdultsCompletedNCT01658696Phase 2
43A Phase 1/2b Study of an Investigational Malaria Vaccination Strategy in 5-17 Month Old Infants and Children in Burkina FasoCompletedNCT01635647Phase 1, Phase 2
44Double-blind, Randomized, Controlled Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria VaccineCompletedNCT00223990Phase 2
45Efficacy and Safety of Dengue Vaccine in Healthy ChildrenCompletedNCT00842530Phase 2
46Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in AfricaCompletedNCT01341704Phase 2
47Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.CompletedNCT00380393Phase 2
48Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian ChildrenCompletedNCT00360230Phase 2
49One-visit Multi-site Intradermal Rabies Vaccination - Dose FindingRecruitingNCT02276625Phase 2
50Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria VaccineRecruitingNCT00652275Phase 2

Search NIH Clinical Center for Rabies


Cochrane evidence based reviews: Rabies

Genetic Tests for Rabies

About this section

Anatomical Context for Rabies

About this section

MalaCards organs/tissues related to Rabies:

33
Brain, Spinal cord, Testes, B cells, Skin, Cortex, Dorsal root ganglion

FMA organs/tissues related to Rabies:

16
Brain or

Animal Models for Rabies or affiliated genes

About this section

MGI Mouse Phenotypes related to Rabies:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00020068.6ALB, IGHM, PML, STAT1, TLR3
2MP:00053847.5ALB, CD40LG, CXCL10, IGHM, NCAM1, NGFR
3MP:00107686.7ALB, CD40LG, CXCL10, IGHM, NCAM1, NGFR
4MP:00053976.5CCL5, CD40LG, CXCL10, IGHM, NGFR, PML
5MP:00053876.2CCL5, CD40LG, CXCL10, IGHM, NGFR, PML

Publications for Rabies

About this section

Articles related to Rabies:

(show top 50)    (show all 617)
idTitleAuthorsYear
1
Erratum: Regulatory Acceptance and Use of Serology for Inactivated Veterinary Rabies Vaccines. (26536289)
2015
2
Concentration and purification of rabies viral and lentiviral vectors. (25834256)
2015
3
Role of dog sterilisation and vaccination in rabies control programmes. (25344046)
2014
4
Strategic model of national rabies control in Korea. (24427765)
2014
5
Rabies: Underused vaccines, unnecessary deaths. (24434045)
2014
6
Rabies surveillance in the United States during 2013. (25356711)
2014
7
A novel site-II directed glycoprotein estimation ELISA to aid rabies vaccine manufacture for veterinary and human use. (24262315)
2014
8
Prioritization of capacities for the elimination of dog-mediated human rabies in the Americas: building the framework. (24392676)
2013
9
Rabies virus nucleoprotein expressed in silkworm pupae at high-levels and evaluation of immune responses in mice. (23178898)
2013
10
Characterization of street rabies virus variants with an additional N-glycan at position 247 in the glycoprotein. (23921623)
2013
11
Epidemiology of urban dog-related injuries requiring rabies post-exposure prophylaxis in Marseille, France. (23116608)
2013
12
Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field. (23201293)
2013
13
Pre-exposure vaccination against rabies: are we being left in the lurch? (24123447)
2013
14
Making rabies prophylaxis more economical: Immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers. (24008819)
2013
15
MRI in rabies encephalitis. (24172782)
2013
16
Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman Moore strain) manufactured in India. (24030586)
2013
17
Costs of rabies control: an economic calculation method applied to flores island. (24386244)
2013
18
Spatial epidemiology of bat-borne rabies in Colombia. (24096979)
2013
19
Gains and future road map for the elimination of dog-transmitted rabies in the americas. (24306030)
2013
20
The introduction of fox rabies into Italy (2008-2011) was due to two viral genetic groups with distinct phylogeographic patterns. (23603764)
2013
21
Comparison of pathogenic domains of rabies and African rabies-related lyssaviruses and pathogenicity observed in mice. (23718883)
2013
22
Relationship between virus-neutralizing antibody levels and the number of rabies vaccinations: a prospective study of dogs in Japan. (23429079)
2013
23
WSAVA and OIE call for action on rabies. (24243670)
2013
24
Prevalence of rabies in various species in yemen and risk factors contributing to the spread of the disease. (23984026)
2013
25
Dog bite histories and response to incidents in canine rabies-enzootic KwaZulu-Natal, South Africa. (23593511)
2013
26
Recent emergence and spread of an Arctic-related phylogenetic lineage of rabies virus in Nepal. (24278494)
2013
27
Characterization of a wild rabies virus isolate of porcine origin in China. (23567821)
2013
28
Evidence-based control of canine rabies: a critical review of population density reduction. (23004351)
2013
29
Economic Evaluation of Vampire Bat (Desmodus rotundus) Rabies Prevention in Mexico. (22984914)
2012
30
Netherlands rabies case highlights importance of following pet travel rules. (22467819)
2012
31
Management of a wild animal bite in a rabies enzootic area. (22860504)
2012
32
Case report: Evidence of rise in rabies cases in southern Malawi--better preventative measures are urgently required. (23638276)
2012
33
Molecular characterization of the complete genome of a street rabies virus WH11 isolated from donkey in China. (22836559)
2012
34
Ecological and anthropogenic drivers of rabies exposure in vampire bats: implications for transmission and control. (22696521)
2012
35
Rabies after corneal transplantation: non-canine rabies and eye banking. (23278792)
2012
36
First human rabies case in French Guiana, 2008: epidemiological investigation and control. (22363830)
2012
37
Susceptibility and lack of evidence for a viremic state of rabies in the night owl monkey, Aotus nancymaae. (22612895)
2012
38
History of Rabies in Traditional Medicine's Resources and Iranian Research Studies: On the CccasiOn of the World Rabies Day (September 28, 2012). (23024845)
2012
39
Small interfering RNAs targeting the rabies virus nucleoprotein gene. (22884777)
2012
40
Request for pictures of rabies vaccine bait. (22435125)
2012
41
Post-exposure prophylaxis against rabies at two newly designated intradermal rabies vaccination clinics in Kerala, India. (23448625)
2012
42
Resistance to rabies. (22855748)
2012
43
Passive immunity in the prevention of rabies. (22541629)
2012
44
Moving from rabies research to rabies control: lessons from India. (22880139)
2012
45
Ambivalent role of the innate immune response in rabies virus pathogenesis. (21525357)
2011
46
Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats. (21632762)
2011
47
Toll-like receptor 3 (TLR3) plays a major role in the formation of rabies virus Negri Bodies. (19247444)
2009
48
The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. (17287281)
2007
49
Role of GPI-anchored NCAM-120 in rabies virus infection. (17208489)
2007
50
Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients. (7483780)
1995

Variations for Rabies

About this section

Expression for genes affiliated with Rabies

About this section
Search GEO for disease gene expression data for Rabies.

Pathways for genes affiliated with Rabies

About this section

Pathways related to Rabies according to GeneCards Suite gene sharing:

(show all 16)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
1
Show member pathways
9.6MX1, STAT1, STAT2
29.6IFNA4, STAT1, STAT2
3
Show member pathways
9.6STAT1, STAT2, TLR3
49.5NCAM1, NGFR, STAT1
59.3CXCL10, STAT1, STAT2
69.3IFNA4, STAT1, STAT2, TLR3
7
Show member pathways
9.1IFNA4, MX1, PML, STAT1, STAT2
8
Show member pathways
8.8IFNA4, MX1, NCAM1, PML, STAT1, STAT2
98.8CCL5, CXCL10, NCAM1
10
Show member pathways
8.5CCL5, CXCL10, STAT1, STAT2
11
Show member pathways
8.4CCL5, CXCL10, IFNA4, TLR3
12
Show member pathways
7.8CCL5, CXCL10, IFNA4, STAT1, STAT2, TLR3
137.5CCL5, CD40LG, CXCL10, NCAM1, STAT1, STAT2
14
Show member pathways
7.3CCL5, CXCL10, IFNA4, MX1, PML, STAT1
15
Show member pathways
7.3CCL5, CD40LG, CXCL10, NGFR, STAT1, STAT2
16
Show member pathways
6.9CD40LG, CXCL10, IFNA4, IGHM, MX1, NCAM1

GO Terms for genes affiliated with Rabies

About this section

Cellular components related to Rabies according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098978.5CD40LG, CXCL10, IGHM, NCAM1, NGFR
2extracellular spaceGO:00056157.4ALB, CCL5, CD40LG, CXCL10, IFNA4, IGHM

Biological processes related to Rabies according to GeneCards Suite gene sharing:

(show all 22)
idNameGO IDScoreTop Affiliating Genes
1interferon-gamma-mediated signaling pathwayGO:006033310.3NCAM1, PML, STAT1
2regulation of type I interferon-mediated signaling pathwayGO:006033810.3IFNA4, STAT1, STAT2
3positive regulation of interleukin-12 productionGO:003273510.3CD40LG, TLR3
4lipopolysaccharide-mediated signaling pathwayGO:003166310.0CCL5, STAT1
5type I interferon signaling pathwayGO:006033710.0IFNA4, MX1, STAT1, STAT2
6defense responseGO:00069529.9IFNA4, MX1, TLR3
7tumor necrosis factor-mediated signaling pathwayGO:00332099.9CD40LG, NGFR, STAT1
8response to exogenous dsRNAGO:00433309.9IFNA4, STAT1, TLR3
9negative regulation of angiogenesisGO:00165259.9CXCL10, PML, STAT1
10leukocyte cell-cell adhesionGO:00071599.8CCL5, CD40LG
11positive regulation of monocyte chemotaxisGO:00900269.5CCL5, CXCL10
12positive regulation of T cell migrationGO:20004069.5CCL5, CXCL10
13response to cytokineGO:00340979.2CCL5, PML, STAT1
14cellular response to lipopolysaccharideGO:00712229.2CCL5, CXCL10, STAT1
15cytokine-mediated signaling pathwayGO:00192219.0IFNA4, MX1, NCAM1, PML, STAT1, STAT2
16response to lipopolysaccharideGO:00324968.8CCL5, CXCL10, NGFR, STAT1
17immune responseGO:00069558.5CCL5, CD40LG, CXCL10, NGFR
18defense response to virusGO:00516078.4CXCL10, IFNA4, MX1, PML, STAT1, STAT2
19response to virusGO:00096158.3CCL5, CXCL10, IFNA4, MX1, TLR3
20inflammatory responseGO:00069548.2CCL5, CD40LG, CXCL10, NGFR, TLR3
21signal transductionGO:00071658.2CXCL10, MX1, NGFR, STAT1, STAT2, TLR3
22innate immune responseGO:00450878.2IFNA4, IGHM, MX1, NCAM1, PML, TLR3

Sources for Rabies

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet